Clinical Trials Browser

Phase 1/2 × Gastrointestinal Neoplasms × Mebendazole × Clear all

NCT03628079 2020-01-22

RepoMeb

Phase 1/2 Terminated

Gastrointestinal

Gastrointestinal Neoplasms, Neoplasms, Unknown Primary